Alpha Tau Medical Ltd Stock Analysis & AI Score
Alpha Tau Medical Ltd (DRTS) has an ST Score of 47.5 (C+), driven by its Momentum (A-) and held back by its Profitability (D+). Analysts rate it Buy with a $18.00 price target (+21.9% upside).
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Biotechnology |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Alpha Tau Medical Ltd (DRTS) has an ST Score of 47.5 (C+), driven by its Momentum (A-) and held back by its Profitability (D+). Analysts rate it Buy with a $18.00 price target (+21.9% upside).
- Strongest
- MomentumA-
- Weakest
- ProfitabilityD+
All factor grades
- MomentumA-
- Financial StrengthB
- ValuationB-
- ForecastB-
- GrowthC-
- ProfitabilityD+
- Piotroski2/9
Contact
DRTS stock: frequently asked questions
What is DRTS's ST Score?
Alpha Tau Medical Ltd (DRTS) has an ST Score of 47.5 (C+), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is DRTS a buy, hold, or sell?
Analysts rate DRTS a Buy, with a price target of $18.00 (+21.9% vs the current price). Our ST Score grades it C+ (47.5/100). The ST Score is a data-driven signal, not a recommendation.
What are DRTS's factor grades?
Valuation B-, Profitability D+, Financial Strength B, Momentum A-, Growth C-, Forecast B-.
What is DRTS's valuation grade?
Alpha Tau Medical Ltd (DRTS) earns a valuation grade of B-, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is DRTS's growth grade?
Alpha Tau Medical Ltd (DRTS) earns a growth grade of C-, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is DRTS's profitability grade?
Alpha Tau Medical Ltd (DRTS) earns a profitability grade of D+, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is DRTS's financial strength grade?
Alpha Tau Medical Ltd (DRTS) earns a financial strength grade of B, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for DRTS?
The average analyst price target for Alpha Tau Medical Ltd (DRTS) is $18.00 from 6 analysts, which is +21.9% versus the recent price of $14.77.
What is DRTS's Piotroski score?
Alpha Tau Medical Ltd (DRTS) has a Piotroski F-Score of 2 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.